Genetic Engineering & Biotechnology News details safety testing done with Taconic models:
"Prior to obtaining regulatory approval for use in humans, novel pharmaceutical drugs require extensive safety testing. Guidelines regarding testing strategies are issued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), an agreement established in 1991 between the regulatory authorities in the United States, European Community (EC), and Japan. These guidelines help drug developers evaluate potential human health risks of pharmaceuticals including genotoxicity, immunotoxicity, and reproductive toxicity."
"Prior to obtaining regulatory approval for use in humans, novel pharmaceutical drugs require extensive safety testing. Guidelines regarding testing strategies are issued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), an agreement established in 1991 between the regulatory authorities in the United States, European Community (EC), and Japan. These guidelines help drug developers evaluate potential human health risks of pharmaceuticals including genotoxicity, immunotoxicity, and reproductive toxicity."
Read the complete article at: Genengnews.com